When Lonza, a Swiss life sciences company, acquired Capsugel, a New Jersey-based contract development and manufacturing organization, in 2017, the organization was faced with a common dilemma: how to merge two cultures and create an innovative compliance program that worked for both. Stacey Hanna, who was then serving as Capsugel’s associate general counsel and senior director of global compliance, stepped into the role of general counsel for global ethics and compliance for all of Lonza and took charge of enhancing the company’s compliance program. The Anti-Corruption Report spoke with Hanna about how she approached designing and implementing a program that met the needs of a growing company. See the Anti-Corruption Report’s three-part series on managing M&A anti-corruption risk: “Pre-Deal Prep” (Oct. 3, 2018); “Pre-Closing Risk Assessments and Due Diligence” (Oct. 17, 2018); and “Deal Terms and Integration” (Oct. 31, 2018).